CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor. 2020

Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
Department of Immuno-Gene Therapy, Mie University Graduate School of Medicine, Tsu, Japan.

Polyfunctionality/multifunctionality of effector T cells at the single cell level has been shown as an important parameter to predict the quality of T cell response and immunological control of infectious disease and malignancy. However, the fate of polyfunctional CD8+ CTLs and the factors that control the polyfunctionality of T cells remain largely unknown. Here we show that the acquisition of polyfunctionality on the initial stimulation is a sensitive immune correlate of CTL survival and memory formation. CD8+ T cells with high polyfunctionality, assessed with γ-interferon and tumor necrosis factor-α production and surface mobilization of the degranulation marker CD107a, showed enhanced Bcl-2 expression, low apoptosis, and increased CD127high KLRG1low memory precursor phenotype. Consistent with these observations, CD8+ T cells were found to acquire high frequency of cells with polyfunctionality when stimulated in conditions known to enhance memory formation, such as the presence of CD4+ T cells, interleukin (IL)-2, or IL-21. Utilizing T-cell receptor (TCR) transgenic mouse-derived CD8+ T cells that express a TCR specific for a tumor-derived neoantigen, we showed that polyfunctional tumor-specific CTLs generated in the presence of CD4+ T cells showed long persistence in vivo and induced enhanced tumor regression when adoptively transferred into mice with progressing tumor. Acquisition of polyfunctionality thus impacts CTL survival and memory formation associated with immunological control of tumor.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
January 2020, Frontiers in immunology,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
January 2014, European journal of immunology,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
June 2002, Proceedings of the National Academy of Sciences of the United States of America,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
January 2012, Nature communications,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
June 2016, Oncoimmunology,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
November 2017, Nature communications,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
January 2016, Scientific reports,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
April 2023, Scientific reports,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
October 2018, Nature communications,
Naoko Imai, and Isao Tawara, and Makiko Yamane, and Daisuke Muraoka, and Hiroshi Shiku, and Hiroaki Ikeda
July 2007, Infection and immunity,
Copied contents to your clipboard!